比较实验与临床研究中的免疫特征以探究淋球菌感染的保护相关因素
本研究利用小鼠生殖道感染模型比较Bexsero、淋球菌外膜囊泡(Ng OMV)与铝佐剂免疫后的系统与黏膜反应,并用淋球菌蛋白微阵列分析抗原特异性IgG。Bexsero显著加速细菌清除,血清与阴道IgG谱高度相关,且Bexsero免疫小鼠与人的抗原特异性IgG模式一致,但杀菌活性(SBA)与清除不相关,早期中性粒细胞(PMN)浸润与细菌载量降低相关。
要点
- Bexsero较Ng OMV或铝佐剂显著加速小鼠淋球菌清除。
- SBA与细菌清除不相关,早期PMN浸润与载量降低相关。
- Bexsero免疫小鼠与人的抗原特异性IgG模式一致。
核心结论
- 蛋白微阵列结合多变量分析识别出与保护相关的抗体特征,支持该模型用于定义保护相关因素并指导淋球菌疫苗开发。
研究设计与样本
- 采用小鼠生殖道感染模型,比较Bexsero、淋球菌外膜囊泡(Ng OMV)加铝佐剂或单用铝佐剂免疫后的系统与黏膜反应,并将小鼠反应与高风险Bexsero免疫人群及淋球菌感染患者比较。
主要发现
- Bexsero较Ng OMV或铝佐剂显著加速细菌清除。
- 血清与阴道IgG谱高度相关,组间抗原特征不同。
- Bexsero诱导针对其重组抗原淋球菌直系同源物(GNA1030、GNA2091、NHBA)的反应,而Ng OMV诱导Opa、PilQ和MtrE反应。
- SBA与清除不相关,早期PMN浸润与细菌载量降低相关。
- Bexsero免疫小鼠与人的抗原特异性IgG模式一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Neisseria gonorrhoeae is a major sexually transmitted pathogen with rising antimicrobial resistance. Epidemiological studies suggest meningococcal outer membrane vesicle (OMV) vaccines, eg 4CMenB (Bexsero), offer partial cross-protection, but immune correlates remain undefined. METHODS: Using a murine genital tract infection model, we compared systemic and mucosal responses after immunization with Bexsero, gonococcal OMVs (Ng OMVs) with alum, or alum alone. Vaccinated mice were challenged intravaginally with N. gonorrhoeae. Serum bactericidal activity (SBA) was measured, and antigen-specific IgG responses were profiled using gonococcal protein microarrays. Murine responses were compared with high-risk Bexsero-immunized humans and patients with gonococcal infection. RESULTS: Bexsero significantly accelerated bacterial clearance compared with Ng OMV or alum. Serum and vaginal IgG profiles were highly correlated, revealing distinct antigenic signatures between groups. Bexsero elicited responses to gonococcal orthologs of its recombinant antigens (GNA1030, GNA2091, NHBA), whereas Ng OMVs induced Opa, PilQ, and MtrE responses. SBA did not correlate with clearance; however, early PMN influx was associated with reduced bacterial load. Antigen-specific IgG patterns were concordant between Bexsero-immunized mice and humans. CONCLUSIONS: Protein microarrays with multivariate analysis identified antibody signatures associated with protection, supporting the translational value of this model for defining correlates of protection and guiding gonococcal vaccine development.
引用
- McKeand SA, Bencomo FR, Soc A, et al. Investigation of Correlates of Protection Against Gonococcal Infection by Comparative Immunoprofiling of Responses in Experimental and Clinical Studies. J Infect Dis. 2026. PMID: 42053374. doi:10.1093/infdis/jiag216
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。